Analytical Data
-
Gene name
AMN
- Application
-
Alternative Names
AMN；Protein amnionless
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P51645
-
Expression Region
20-357aa
-
AA Sequence
MGSSHHHHHHSSGLVPRGSHMGSVSKLWVPNTDFDVAANWSQNRTPCAGG AVEFPADKMVSVLVQEGHAVSDMLLPLDGELVLASGAGFGVSDVGSHLDC GAGEPAVFRDSDRFSWHDPHLWRSGDEAPGLFFVDAERVPCRHDDVFFPP SASFRVGLGPGASPVRVRSISALGRTFTRDEDLAVFLASRAGRLRFHGPG ALSVGPEDCADPSGCVCGNAEAQPWICAALLQPLGGRCPQAACHSALRPQ GQCCDLCGAVVLLTHGPAFDLERYRARILDTFLGLPQYHGLQVAVSKVPR SSRLREADTEIQVVLVENGPETGGAGRLARALLADVAENGEALGVLEATM RESGAHVWGSS
-
Molecular Weight
38 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
AMN (Amnion-derived Multilineage-Inducible) proteins are a class of proteins that have garnered attention due to their potential applications in regenerative medicine and tissue engineering. Derived from the amniotic membrane, these proteins exhibit unique properties, including anti-inflammatory effects and the ability to promote cell proliferation and differentiation. Research into AMN proteins began as scientists sought to harness the regenerative potential of amniotic tissues, which are rich in stem cells and growth factors. The interest in these proteins has expanded as studies have demonstrated their roles in modulating immune responses and supporting tissue repair in various models of injury and disease. Furthermore, AMN proteins have been explored for their possible use in treating conditions such as chronic wounds, cardiovascular diseases, and neurological disorders, where traditional therapies may fall short. Ongoing investigations aim to elucidate the molecular mechanisms underlying the beneficial effects of AMN proteins and to optimize their application in clinical settings. The growing body of literature indicates that AMN proteins may represent a promising frontier in the development of novel therapeutic strategies aimed at enhancing healing and tissue regeneration.
